药店推行阴阳价，别把医保卡当套利卡

Core Viewpoint - The article highlights the issue of "dual pricing" in pharmacies, where the price of a medication is higher when paid through health insurance compared to cash payments, leading to increased costs for insured individuals and undermining the integrity of the health insurance system [1][2][3] Group 1: Pricing Mechanism - The phenomenon of "dual pricing" results in insured individuals facing higher medication costs, transforming health insurance personal accounts into tools for paying inflated prices [2] - Pharmacies exploit the lack of sensitivity among insured individuals regarding their health insurance accounts, creating a dilemma where consumers feel they lose money regardless of their payment method [1][2] Group 2: Impact on Health Insurance System - The existence of price discrepancies diminishes public trust in the health insurance system, as individuals realize they cannot purchase medications at equivalent prices using their insurance [2] - The practice of "dual pricing" is seen as a means for pharmacies to extract funds from health insurance, potentially leading to fraudulent behaviors and significant leakage of health insurance funds [2] Group 3: Regulatory Recommendations - To address these issues, it is recommended that health insurance authorities establish a dynamic price monitoring mechanism and enhance daily management of designated pharmacies, including increased inspections and penalties for violations [2][3] - The implementation of immediate settlement reforms for health insurance funds is suggested to alleviate financial pressure on pharmacies, thereby reducing the incentive for "dual pricing" practices [3] - A graded management system for designated pharmacies should be established, linking compliance with pricing to health insurance payment limits, rewarding compliant operators while penalizing violators [3]